Search by topic:


A drug that slows Alzheimer's

post-image
Generic placeholder image

8 January 2023 by IdeaSpies

The drug, Leqembi, is the first to convincingly show it can slow the decline in memory and thinking that defines Alzheimer’s by targeting its underlying biology. The FDA approved it for patients with Alzheimer’s, specifically those with mild or early-stage disease.

Leqembi, from Japan’s Eisai and its US partner Biogen, is a rare success in a field accustomed to failed experimental treatments for the incurable condition. The delay in cognitive decline brought about by the drug likely amounts to just several months, but some experts say it could still meaningfully improve people’s lives.

https://www.smh.com.au/world/north-america/us-approves-alzheimer-s-drug-that-modestly-slows-disease-20230107-p5cayi.html



What do you think?


You must be logged in to post a comment.
Comments

Related Posts

Healthcare

post-image

Future Therapist Chatbot
22 January 2023 by Prof.(Dr.) Sa... 0 Comments

Healthcare

post-image

A wearable smart badge that can translate your speech
21 January 2023 by IdeaSpies 0 Comments

Healthcare

post-image

Social Media Platform that Connects People with Similar Health Conditions
18 January 2023 by Jeremy Ungar 0 Comments